SYNERGY CHC CORP (SNYR) Fundamental Analysis & Valuation

NASDAQ:SNYR • US87165D2080

1.34 USD
0 (0%)
Last: Mar 6, 2026, 08:00 PM

This SNYR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SNYR. SNYR was compared to 37 industry peers in the Personal Care Products industry. Both the profitability and the financial health of SNYR get a neutral evaluation. Nothing too spectacular is happening here. SNYR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. SNYR Profitability Analysis

1.1 Basic Checks

  • In the past year SNYR was profitable.
  • SNYR had a negative operating cash flow in the past year.
SNYR Yearly Net Income VS EBIT VS OCF VS FCFSNYR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2023 2024 0 5M -5M 10M

1.2 Ratios

  • The Return On Assets of SNYR (12.47%) is better than 86.49% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 29.10%, SNYR belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
Industry RankSector Rank
ROA 12.47%
ROE N/A
ROIC 29.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNYR Yearly ROA, ROE, ROICSNYR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

  • SNYR has a better Profit Margin (7.46%) than 78.38% of its industry peers.
  • SNYR's Operating Margin of 17.95% is amongst the best of the industry. SNYR outperforms 91.89% of its industry peers.
  • In the last couple of years the Operating Margin of SNYR has grown nicely.
  • SNYR's Gross Margin of 71.08% is fine compared to the rest of the industry. SNYR outperforms 67.57% of its industry peers.
  • SNYR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.95%
PM (TTM) 7.46%
GM 71.08%
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
SNYR Yearly Profit, Operating, Gross MarginsSNYR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2023 2024 0 20 -20 40 60

4

2. SNYR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNYR is creating value.
  • Compared to 1 year ago, SNYR has more shares outstanding
  • The number of shares outstanding for SNYR has been increased compared to 5 years ago.
  • Compared to 1 year ago, SNYR has an improved debt to assets ratio.
SNYR Yearly Shares OutstandingSNYR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2023 2024 20M 40M 60M 80M
SNYR Yearly Total Debt VS Total AssetsSNYR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of 1.13, we must say that SNYR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.13, SNYR is doing worse than 62.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACC2.54
WACC11.46%
SNYR Yearly LT Debt VS Equity VS FCFSNYR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • SNYR has a Current Ratio of 5.35. This indicates that SNYR is financially healthy and has no problem in meeting its short term obligations.
  • SNYR has a better Current ratio (5.35) than 94.59% of its industry peers.
  • A Quick Ratio of 4.79 indicates that SNYR has no problem at all paying its short term obligations.
  • The Quick ratio of SNYR (4.79) is better than 94.59% of its industry peers.
Industry RankSector Rank
Current Ratio 5.35
Quick Ratio 4.79
SNYR Yearly Current Assets VS Current LiabilitesSNYR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M

4

3. SNYR Growth Analysis

3.1 Past

  • SNYR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.60%.
  • The Revenue for SNYR has decreased by -18.57% in the past year. This is quite bad
  • SNYR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.48% yearly.
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.04%
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%12.4%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.84% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 16.07% on average over the next years. This is quite good.
EPS Next Y-25%
EPS Next 2Y-7.2%
EPS Next 3Y28.84%
EPS Next 5YN/A
Revenue Next Year0.1%
Revenue Next 2Y18.71%
Revenue Next 3Y16.07%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNYR Yearly Revenue VS EstimatesSNYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
SNYR Yearly EPS VS EstimatesSNYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6

6

4. SNYR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 4.62, which indicates a rather cheap valuation of SNYR.
  • Based on the Price/Earnings ratio, SNYR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, SNYR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 4.24, the valuation of SNYR can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SNYR indicates a rather cheap valuation: SNYR is cheaper than 97.30% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, SNYR is valued rather cheaply.
Industry RankSector Rank
PE 4.62
Fwd PE 4.24
SNYR Price Earnings VS Forward Price EarningsSNYR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SNYR is valued cheaper than 86.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.27
SNYR Per share dataSNYR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • SNYR's earnings are expected to grow with 28.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.2%
EPS Next 3Y28.84%

0

5. SNYR Dividend Analysis

5.1 Amount

  • No dividends for SNYR!.
Industry RankSector Rank
Dividend Yield 0%

SNYR Fundamentals: All Metrics, Ratios and Statistics

SYNERGY CHC CORP

NASDAQ:SNYR (3/6/2026, 8:00:02 PM)

1.34

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners11.53%
Inst Owner ChangeN/A
Ins Owners6.97%
Ins Owner Change0%
Market Cap15.07M
Revenue(TTM)34.59M
Net Income(TTM)2.58M
Analysts82.5
Price Target6.12 (356.72%)
Short Float %0.23%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)53.19%
Min EPS beat(2)-1.96%
Max EPS beat(2)108.33%
EPS beat(4)2
Avg EPS beat(4)14.06%
Min EPS beat(4)-90.2%
Max EPS beat(4)108.33%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-27.06%
Min Revenue beat(2)-27.95%
Max Revenue beat(2)-26.16%
Revenue beat(4)0
Avg Revenue beat(4)-17.48%
Min Revenue beat(4)-27.95%
Max Revenue beat(4)-4.54%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.29%
PT rev (3m)-14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-34.15%
Revenue NQ rev (1m)-1.99%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-18.64%
Valuation
Industry RankSector Rank
PE 4.62
Fwd PE 4.24
P/S 0.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 6.27
EPS(TTM)0.29
EY21.64%
EPS(NY)0.32
Fwd EY23.6%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS3.07
BVpS-0.73
TBVpS-0.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 12.47%
ROE N/A
ROCE 36.83%
ROIC 29.1%
ROICexc 30.97%
ROICexgc 31.33%
OM 17.95%
PM (TTM) 7.46%
GM 71.08%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
F-Score3
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.02
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.88
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.35
Quick Ratio 4.79
Altman-Z 1.13
F-Score3
WACC11.46%
ROIC/WACC2.54
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.04%
EPS Next Y-25%
EPS Next 2Y-7.2%
EPS Next 3Y28.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%12.4%
Revenue Next Year0.1%
Revenue Next 2Y18.71%
Revenue Next 3Y16.07%
Revenue Next 5YN/A
EBIT growth 1Y-46.32%
EBIT growth 3YN/A
EBIT growth 5Y26.96%
EBIT Next Year39.9%
EBIT Next 3Y24.27%
EBIT Next 5YN/A
FCF growth 1Y-1239.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1239.06%
OCF growth 3YN/A
OCF growth 5YN/A

SYNERGY CHC CORP / SNYR FAQ

Can you provide the ChartMill fundamental rating for SYNERGY CHC CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SNYR.


What is the valuation status of SYNERGY CHC CORP (SNYR) stock?

ChartMill assigns a valuation rating of 6 / 10 to SYNERGY CHC CORP (SNYR). This can be considered as Fairly Valued.


What is the profitability of SNYR stock?

SYNERGY CHC CORP (SNYR) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SYNERGY CHC CORP (SNYR) stock?

The Price/Earnings (PE) ratio for SYNERGY CHC CORP (SNYR) is 4.62 and the Price/Book (PB) ratio is -1.83.


How financially healthy is SYNERGY CHC CORP?

The financial health rating of SYNERGY CHC CORP (SNYR) is 4 / 10.